A Phase Ib Combination Study of Rituximab, TinostamustinEAnd CHeckpoint Inhibition With Pembrolizumab in Relapsed/Refractory DLBCL
Clinical trial NCT04279938 · WITHDRAWN
Trial details
- NCT number
- NCT04279938
- Sponsor
- Royal Marsden NHS Foundation Trust
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-01
- Primary completion
- 2020-03-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.